| Hans-Günter Meyer-Thompson | Buprenorphin
Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study.
Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study.
Strang J, Reed K, Bogdanowicz K, Bell J, van der Waal R, Keen J, Beavan P, Baillie S, Knight A.
Eur Addict Res. 2017 Mar 8;23(2):61-70. doi: 10.1159/000456612.
Abstract